A Study of AT-1965 in People With Solid Tumors

Full Title

A Phase 1/2 Open-Label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of AT-1965 in Patients with Advanced, Refractory, or Recurrent Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Mrinal Gounder’s office at 646-888-4167.

Protocol
26-278
Phase
Phase I/II (phases 1 and 2 combined)
Investigator
Mrinal M. Gounder
Co-Investigators
Robert Maki
Diseases
Solid Tumors
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06234098
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description